ReP USP - Resultado da busca

Filtros : "Szabó, C." Removido: "2003" Limpar

Filtros

Artigo de periodico
NFkB1 (P50) deficient mice are not susceptible to multiple low-dose streptozotocin: induced diabetes (2002)
Mabley, J. G.; Haskó, G.; Liaudet, L.; Soriano, Francisco Garcia; Southan, G. J.; Salzman, A. L.; Szabó, C.
Source: Journal of Endocrinology. Unidade: FM
Assunto: DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MABLEY, J. G. et al. NFkB1 (P50) deficient mice are not susceptible to multiple low-dose streptozotocin: induced diabetes. Journal of Endocrinology, v. 173, n. 3, p. 457-464, 2002Tradução . . Acesso em: 14 nov. 2024.
APA
Mabley, J. G., Haskó, G., Liaudet, L., Soriano, F. G., Southan, G. J., Salzman, A. L., & Szabó, C. (2002). NFkB1 (P50) deficient mice are not susceptible to multiple low-dose streptozotocin: induced diabetes. Journal of Endocrinology, 173( 3), 457-464.
NLM
Mabley JG, Haskó G, Liaudet L, Soriano FG, Southan GJ, Salzman AL, Szabó C. NFkB1 (P50) deficient mice are not susceptible to multiple low-dose streptozotocin: induced diabetes. Journal of Endocrinology. 2002 ; 173( 3): 457-464.[citado 2024 nov. 14 ]
Vancouver
Mabley JG, Haskó G, Liaudet L, Soriano FG, Southan GJ, Salzman AL, Szabó C. NFkB1 (P50) deficient mice are not susceptible to multiple low-dose streptozotocin: induced diabetes. Journal of Endocrinology. 2002 ; 173( 3): 457-464.[citado 2024 nov. 14 ]
Artigo de periodico
Anti-inflamatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase (2001)
Mabley, J. G.; Jagtap, P.; Perreti, M.; Getting, S. J.; Salzman, A. L.; Virág, L.; Szabó, É.; Liaudet, L.; Bdelkarim, G. E.; Haskó, G.; Marton, A.; Southan, G. J.; Szabó, C.; Soriano, Francisco Garcia
Source: Inflammation Research. Unidade: FM
Subjects: ARTRITE, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MABLEY, J. G. et al. Anti-inflamatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflammation Research, n. 50, p. 561-569, 2001Tradução . . Disponível em: https://doi.org/10.1007/pl00000234. Acesso em: 14 nov. 2024.
APA
Mabley, J. G., Jagtap, P., Perreti, M., Getting, S. J., Salzman, A. L., Virág, L., et al. (2001). Anti-inflamatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflammation Research, ( 50), 561-569. doi:10.1007/pl00000234
NLM
Mabley JG, Jagtap P, Perreti M, Getting SJ, Salzman AL, Virág L, Szabó É, Liaudet L, Bdelkarim GE, Haskó G, Marton A, Southan GJ, Szabó C, Soriano FG. Anti-inflamatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase [Internet]. Inflammation Research. 2001 ;( 50): 561-569.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/pl00000234
Vancouver
Mabley JG, Jagtap P, Perreti M, Getting SJ, Salzman AL, Virág L, Szabó É, Liaudet L, Bdelkarim GE, Haskó G, Marton A, Southan GJ, Szabó C, Soriano FG. Anti-inflamatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase [Internet]. Inflammation Research. 2001 ;( 50): 561-569.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/pl00000234

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024